These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24948381)

  • 21. Gene-gene interaction of glycogen synthase kinase 3-β and serotonin transporter on human antidepressant response to sleep deprivation.
    Benedetti F; Dallaspezia S; Lorenzi C; Pirovano A; Radaelli D; Locatelli C; Poletti S; Colombo C; Smeraldi E
    J Affect Disord; 2012 Feb; 136(3):514-9. PubMed ID: 22119086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GSK3B and schizophrenia: a case not closed.
    Sand PG; Domani M; Smesny S
    Psychopharmacology (Berl); 2010 Feb; 208(2):333-4; author reply 335-6. PubMed ID: 19936977
    [No Abstract]   [Full Text] [Related]  

  • 23. Association between GSK3β gene and increased impulsivity in bipolar disorder.
    Jiménez E; Arias B; Mitjans M; Goikolea JM; Roda E; Ruíz V; Pérez A; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Vieta E; Benabarre A
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):510-8. PubMed ID: 24486183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depression.
    Saus E; Soria V; Escaramís G; Crespo JM; Valero J; Gutiérrez-Zotes A; Martorell L; Vilella E; Menchón JM; Estivill X; Gratacòs M; Urretavizcaya M
    Genes Brain Behav; 2010 Oct; 9(7):799-807. PubMed ID: 20618448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in GSK3beta gene copy number variation in bipolar disorder.
    Lachman HM; Pedrosa E; Petruolo OA; Cockerham M; Papolos A; Novak T; Papolos DF; Stopkova P
    Am J Med Genet B Neuropsychiatr Genet; 2007 Apr; 144B(3):259-65. PubMed ID: 17357145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity.
    Benedetti F; Poletti S; Radaelli D; Bernasconi A; Cavallaro R; Falini A; Lorenzi C; Pirovano A; Dallaspezia S; Locatelli C; Scotti G; Smeraldi E
    Genes Brain Behav; 2010 Jun; 9(4):365-71. PubMed ID: 20113358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ascl1a/Dkk/beta-catenin signaling pathway is necessary and glycogen synthase kinase-3beta inhibition is sufficient for zebrafish retina regeneration.
    Ramachandran R; Zhao XF; Goldman D
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15858-63. PubMed ID: 21911394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorder.
    Benedetti F; Bollettini I; Barberi I; Radaelli D; Poletti S; Locatelli C; Pirovano A; Lorenzi C; Falini A; Colombo C; Smeraldi E
    Neuropsychopharmacology; 2013 Jan; 38(2):313-27. PubMed ID: 22990942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haplotype analysis of GSK-3β gene polymorphisms in bipolar disorder lithium responders and nonresponders.
    Iwahashi K; Nishizawa D; Narita S; Numajiri M; Murayama O; Yoshihara E; Onozawa Y; Nagahori K; Fukamauchi F; Ikeda K; Ishigooka J
    Clin Neuropharmacol; 2014; 37(4):108-10. PubMed ID: 24992082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.
    Lin YF; Huang MC; Liu HC
    J Affect Disord; 2013 May; 147(1-3):401-6. PubMed ID: 23021822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine D
    Chang PK; Chu J; Tsai YT; Lai YH; Chen JC
    J Biomed Sci; 2020 Jan; 27(1):16. PubMed ID: 31900153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association study of -1727 A/T, -50 C/T and (CAA)n repeat GSK-3beta gene polymorphisms with schizophrenia.
    Scassellati C; Bonvicini C; Perez J; Bocchio-Chiavetto L; Tura GB; Rossi G; Racagni G; Gennarelli M
    Neuropsychobiology; 2004; 50(1):16-20. PubMed ID: 15179015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No association of GSK3beta gene (GSK3B) with Japanese schizophrenia.
    Ikeda M; Iwata N; Suzuki T; Kitajima T; Yamanouchi Y; Kinoshita Y; Ozaki N
    Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):90-2. PubMed ID: 15719395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results.
    Bersudsky Y; Shaldubina A; Kozlovsky N; Woodgett JR; Agam G; Belmaker RH
    Behav Pharmacol; 2008 May; 19(3):217-24. PubMed ID: 18469539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The relationship between glycogen synthase kinase-3 beta (GSK3B) -50T/C -1727A/T polymorphisms and alcoholism].
    Yoshihara E; Aoki J; Kurihara K; Numajiri M; Iwahashi K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2011 Dec; 46(6):570-5. PubMed ID: 22413565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal signaling pathways: genetic insights into the pathophysiology of major mental illness.
    Margolis RL; Ross CA
    Neuropsychopharmacology; 2010 Jan; 35(1):350-1. PubMed ID: 20010716
    [No Abstract]   [Full Text] [Related]  

  • 38. Regulation of glycogen synthase kinase-3 in patients with affective disorders.
    O'Brien WT; Klein PS
    Biol Psychiatry; 2007 Jan; 61(2):139-41. PubMed ID: 17223440
    [No Abstract]   [Full Text] [Related]  

  • 39. The TRAX, DISC1, and GSK3 complex in mental disorders and therapeutic interventions.
    Weng YT; Chien T; Kuan II; Chern Y
    J Biomed Sci; 2018 Oct; 25(1):71. PubMed ID: 30285728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder.
    Benedetti F; Poletti S; Radaelli D; Locatelli C; Pirovano A; Lorenzi C; Vai B; Bollettini I; Falini A; Smeraldi E; Colombo C
    Psychopharmacology (Berl); 2015 Apr; 232(7):1325-36. PubMed ID: 25345732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.